1 Department of Urology, Zhejiang Xiaoshan Hospital, Hangzhou, China.
2 Department of Medical Examination Center, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Int J Immunopathol Pharmacol. 2019 Jan-Dec;33:2058738419863217. doi: 10.1177/2058738419863217.
Primary prostate lymphoma (PPL) is rare. This article reports a case of PPL by retrospective analysis of the clinical data and review of the literature, in an attempt to explore the diagnosis, treatment, and prognosis of this rare disease. The present case involves a male patient who came to our hospital for medical consultation of dysuria. Serum prostate-specific antigen (PSA) was not remarkable. Pelvic computed tomography (CT) scan suggested obvious enlargement of the prostate and a tumor in the prostate, but the tumor was not significantly enhanced on contrast-enhanced CT scan. Ultrasound suggested obvious enlargement of the prostate with multiple local low-density echoes and rich blood flow signals inside. Histopathology of prostate biopsy suggested prostate diffuse large B-cell lymphoma (DLBCL). The patient refused chemotherapy but agreed to receive radiotherapy. After radiotherapy, the tumor became smaller and the International Prostate Symptom Score (IPSS) score was reduced. Our experience, together with literature review, suggests that prostate puncture biopsy is an important method for the diagnosis of PPL, and imaging examination can assist the diagnosis. Radiotherapy is able to reduce the tumor volume and relieve the symptoms of urinary tract obstruction, and chemotherapy can help achieve a better therapeutic outcome.
原发性前列腺淋巴瘤(PPL)较为罕见。本文通过对临床资料的回顾性分析并复习文献,报道 1 例 PPL 病例,旨在探讨该罕见疾病的诊断、治疗及预后。本病例为 1 例因排尿困难就诊于我院的男性患者,血清前列腺特异性抗原(PSA)无明显升高。盆腔 CT 扫描提示前列腺明显肿大,前列腺内见一肿物,但增强 CT 扫描未见肿物明显强化。超声提示前列腺明显肿大,其内见多个局灶性低回声,内部血流信号丰富。前列腺穿刺活检病理提示前列腺弥漫性大 B 细胞淋巴瘤(DLBCL)。患者拒绝化疗,但同意接受放疗。放疗后,肿瘤缩小,国际前列腺症状评分(IPSS)降低。我们的经验结合文献复习认为,前列腺穿刺活检是诊断 PPL 的重要方法,影像学检查有助于诊断。放疗能够缩小肿瘤体积,缓解尿路梗阻症状,化疗有助于获得更好的治疗效果。